Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Regarding bone metabolism markers, the OF group showed higher levels of CTx than any other group, and both OF and OA groups presented lower vitamin D levels than the Ctrl group (Table 1).Anthropometric, biochemical and bone characteristics of the study cohort.Control (N = 52)Osteoarthritis (N = 23)Fracture (N = 25)ANOVAp valueAge (years)65.5 ± 6.869.9 ± 9.776.8 ± 8.3 (a,b) < 0.0000Weight (kg)69.4 ± 11.768.7 ± 11.168.0 ± 10.60.861Height (cm)157.5 ± 6.6157.9 ± 5.1156.1 ± 4.00.495BMI (kg/m2)28.1 ± 4.927.5 ± 3.927.9 ± 4.10.877FN-BMD (g/cm2)0.780 ± 0.1620.800 ± 0.1410.640 ± 0.122 (b,c)0.0002FN T-score− 1.175 ± 1.442− 0.313 ± 0.996− 2.457 ± 1.075 (c,d)0.00001FN Z-score0.144 ± 1.4310.873 ± 1.061− 0.795 ± 0.770 (c,d)0.0005LS-BMD (g/cm2)0.992 ± 0.1701.033 ± 0.1540.922 ± 0.1490.055LS T-score− 1.216 ± 1.445− 0.585 ± 1.455− 1.794 ± 1.7010.097LS Z-score0.377 ± 1.5770.954 ± 1.4720.294 ± 1.6760.455CTx (ng/ml)0.367 ± 0.1530.443 ± 0.1560.659 ± 0.220 (a,b) < 0.0000Total-ALP (U/l)170.7 ± 39.9144.6 ± 73.0176.8 ± 92.10.17625(OH)D3 (ng/ml)25.9 ± 9.716.5 ± 9.2 (c)14.4 ± 10.9 (e) < 0.0000BMI body mass index, BMD bone mineral density, FN femoral neck, LS lumbar spine, CTx carboxy-terminal telopeptides of collagen I, ALP alkaline phosphatase, 25(OH)D3 25-hydroxycholecalciferol.a: p < 0.0000 vs. control.b: p < 0.01 vs. osteoarthritis.c: p < 0.01 vs. control.d: p < 0.0001 vs. osteoarthritis.e: p < 0.0001 vs. control.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Women were determined as controls by a self-report, their medical history, and the examinations of the clinicians of our service.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Serum microRNAs in osteoporotic fracture and osteoarthritis: a genetic and functional study
Study design awaiting verification · Scientific Reports · 2021
Original publication title
Serum microRNAs in osteoporotic fracture and osteoarthritis: a genetic and functional study
© The Author(s) 2021
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
The rising incidence of bone pathologies such as osteoporosis and osteoarthritis is negatively affecting the functional status of millions of patients worldwide. The genetic component of these multifactorial pathologies is far from being fully understood, but in recent years several epigenetic mechanisms involved in the pathophysiology of these bone diseases have been identified. The aim of the present study was to compare the serum expression of four miRNAs in women with hip fragility fracture (OF group), osteoarthritis requiring hip replacement (OA group) and control women (Ctrl group).
Serum expression of miR-497-5p, miR-155-5p, miR-423-5p and miR-365-3p was determined in a sample of 23 OA women, 25 OF women and 52 Ctrl women. Data shown that women with bone pathologies have higher expression of miR-497 and miR-423 and lower expression of miR-155 and miR-365 than control subjects. Most importantly, miR-497 was identified as an excellent discriminator between OA group and control group (AUC: 0.89, p < 0.000) and acceptable in distinguishing from the OF group (AUC: 0.76, p = 0.002).
Our data suggest that circulating miR-497 may represent a significant biomarker of OA, a promising finding that could contribute towards future early-stage diagnosis of this disease. Further studies are required to establish the role of miR-155, miR-423 and miR-365 in bone pathologies.
Authors’ abstract
The rising incidence of bone pathologies such as osteoporosis and osteoarthritis is negatively affecting the functional status of millions of patients worldwide. The genetic component of these multifactorial pathologies is far from being fully understood, but in recent years several epigenetic mechanisms involved in the pathophysiology of these bone diseases have been identified. The aim of the present study was to compare the serum expression of four miRNAs in women with hip fragility fracture (OF group), osteoarthritis requiring hip replacement (OA group) and control women (Ctrl group).
Serum expression of miR-497-5p, miR-155-5p, miR-423-5p and miR-365-3p was determined in a sample of 23 OA women, 25 OF women and 52 Ctrl women. Data shown that women with bone pathologies have higher expression of miR-497 and miR-423 and lower expression of miR-155 and miR-365 than control subjects. Most importantly, miR-497 was identified as an excellent discriminator between OA group and control group (AUC: 0.89, p < 0.000) and acceptable in distinguishing from the OF group (AUC: 0.76, p = 0.002).
Our data suggest that circulating miR-497 may represent a significant biomarker of OA, a promising finding that could contribute towards future early-stage diagnosis of this disease. Further studies are required to establish the role of miR-155, miR-423 and miR-365 in bone pathologies.
Publication and source details
Original title: Serum microRNAs in osteoporotic fracture and osteoarthritis: a genetic and functional study
Clara Pertusa; Juan J. Tarín; Antonio Cano; Miguel Ángel García-Pérez; Damián Mifsut
Scientific Reports · 2021
© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.http://dx.doi.org/10.13039/501100004587Instituto de Salud Carlos IIIPI17/01875García-Pérez Miguel ÁngelRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T11:40:41.012452+00:00
DOI: 10.1038/s41598-021-98789-w · PMC8481273